Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Urticaria
Clinical narrative: Local redness; Local Itching; 6-7 episodes of hives; rash on left elbow; new onset of shingles; pain around waist; face felt hot; rash on face; rash on the neck; rash on knees/ rash on underarms/ rash on chest; hypersensitivity reaction; rash on left arm; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (new onset of shingles), FEELING HOT (face felt hot), ERYTHEMA (Local redness), PRURITUS (Local Itching) and HYPERSENSITIVITY (hypersensitivity reaction) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039A20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer. Concurrent medical conditions included Drug allergy (some pain medications), Allergic reaction to chemotherapy (neuropathy), Sinus infection and Anaphylaxis. Concomitant products included LEVOTHYROXINE for Hypothyroidism, RIZATRIPTAN BENZOATE (MAXALT) for Migraine, GABAPENTIN for Neuropathy, MONTELUKAST SODIUM (SINGULAIR), VITAMIN C [ASCORBIC ACID], NICOTINAMIDE, PYRIDOXINE HYDROCHLORIDE, RIBOFLAVIN, THIAMINE HYDROCHLORIDE (B COMPLEX [NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RIBOFLAVIN;THIAMINE HYDROCHLORIDE]), VITAMIN D3, ZINC and MAGNESIUM for an unknown indication.   On 15-Jan-2021 at 3:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021 at 3:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Mar-2021 at 8:00 AM, the patient experienced HYPERSENSITIVITY (hypersensitivity reaction). On 17-Apr-2021, the patient experienced FEELING HOT (face felt hot), RASH (rash on face), RASH (rash on the neck) and RASH (rash on knees/ rash on underarms/ rash on chest). On 05-May-2021, the patient experienced ABDOMINAL PAIN (pain around waist). On 07-May-2021, the patient experienced HERPES ZOSTER (new onset of shingles). On an unknown date, the patient experienced ERYTHEMA (Local redness), PRURITUS (Local Itching), URTICARIA (6-7 episodes of hives) and RASH (rash on left elbow). an unknown date, the patient experienced RASH (rash on left arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (oral) at a dose of 1 dosage form and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at a dose of 1 dosage form. On 26-Mar-2021 at 8:00 AM, HYPERSENSITIVITY (hypersensitivity reaction) had resolved. On 17-Apr-2021, FEELING HOT (face felt hot), RASH (rash on face), RASH (rash on the neck) and RASH (rash on knees/ rash on underarms/ rash on chest) had resolved. On 07-May-2021, URTICARIA (6-7 episodes of hives) had resolved. At the time of the report, HERPES ZOSTER (new onset of shingles), PRURITUS (Local Itching), ABDOMINAL PAIN (pain around waist) and RASH (rash on left elbow) outcome was unknown, ERYTHEMA (Local redness) had not resolved and RASH (rash on left arm) had resolved.            No lab data has been provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Significant follow up received. Allergy conditions anaphylaxis and Current condition sinus infection added. Treatment medication Zyrtec added.